We are live!!

This was our fourth annual Precision Oncology Experimental Therapeutics (POET) meeting, but our first virtual one. COVID has definitely changed the conference world for at least a year and a half I think.
All seemed to have gone well and the feedback is good. Probably the sessions on Clinical Trial Design and Adoption of NGS in oncology were the most well received.